Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · IEX Real-Time Price · USD
34.65
-0.17 (-0.49%)
At close: Jul 19, 2024, 4:00 PM
34.66
+0.01 (0.03%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Vera Therapeutics Employees
Vera Therapeutics had 51 employees as of December 31, 2023. The number of employees increased by 5 or 10.87% compared to the previous year.
Employees
51
Change (1Y)
5
Growth (1Y)
10.87%
Revenue / Employee
n/a
Profits / Employee
-$1,849,098
Market Cap
1.90B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 51 | 5 | 10.87% |
Dec 31, 2022 | 46 | 9 | 24.32% |
Dec 31, 2021 | 37 | 9 | 32.14% |
Dec 31, 2020 | 28 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
National HealthCare | 13,123 |
Warby Parker | 3,491 |
NeoGenomics | 2,100 |
Amphastar Pharmaceuticals | 1,761 |
Novavax | 1,543 |
Alignment Healthcare | 1,536 |
LeMaitre Vascular | 630 |
Mirum Pharmaceuticals | 264 |
VERA News
- 16 days ago - Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Vera Therapeutics Appoints Christy J. Oliger to Board of Directors - GlobeNewsWire
- 6 weeks ago - Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN) - GlobeNewsWire
- 2 months ago - Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress - GlobeNewsWire
- 2 months ago - Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 5 months ago - Vera Therapeutics to Participate at the 44th Annual TD Cowen Health Care Conference - GlobeNewsWire